Drug recall · April 1, 2026
Meclizine Hydrochloride Tablets recall
Why: Failed tablet specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
- Lots / codes
Lot #1024852; Exp 9/30/2026
- Quantity
- 697 cartons
- Company
- Amerisource Health Services LLC, Columbus, OH
- Distribution
- U.S. Nationwide
- Initiated
- March 16, 2026 · Voluntary: Firm initiated
- Classified
- March 31, 2026
- Reported
- April 1, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Meclizine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.